MEIHUA INTERNATIONAL MEDICAL (MHUA)
KYG5966G1082 - Common Stock
MHUA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. MHUA has an excellent financial health rating, but there are some minor concerns on its profitability. MHUA has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year MHUA was profitable.
In the past year MHUA had a positive cash flow from operations.
In the past 5 years MHUA has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: MHUA reported negative operating cash flow in multiple years.
1.2 Ratios
MHUA has a better Return On Assets (9.12%) than 90.37% of its industry peers.
The Return On Equity of MHUA (10.93%) is better than 85.03% of its industry peers.
With an excellent Return On Invested Capital value of 8.53%, MHUA belongs to the best of the industry, outperforming 87.70% of the companies in the same industry.
MHUA had an Average Return On Invested Capital over the past 3 years of 8.98%. This is in line with the industry average of 8.23%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.12% | ||
| ROE | 10.93% | ||
| ROIC | 8.53% |
ROA(3y)8.61%
ROA(5y)12.96%
ROE(3y)10.61%
ROE(5y)16.01%
ROIC(3y)8.98%
ROIC(5y)13.13%
1.3 Margins
MHUA has a better Profit Margin (11.47%) than 87.17% of its industry peers.
In the last couple of years the Profit Margin of MHUA has declined.
MHUA's Operating Margin of 14.44% is amongst the best of the industry. MHUA outperforms 85.03% of its industry peers.
In the last couple of years the Operating Margin of MHUA has declined.
The Gross Margin of MHUA (33.97%) is worse than 71.12% of its industry peers.
In the last couple of years the Gross Margin of MHUA has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.44% | ||
| PM (TTM) | 11.47% | ||
| GM | 33.97% |
OM growth 3Y-16.94%
OM growth 5Y-9.84%
PM growth 3Y-17.5%
PM growth 5Y-10.18%
GM growth 3Y-6.44%
GM growth 5Y-4.15%
2. Health
2.1 Basic Checks
MHUA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for MHUA remains at a similar level compared to 1 year ago.
MHUA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MHUA has a worse debt to assets ratio.
2.2 Solvency
MHUA has an Altman-Z score of 3.22. This indicates that MHUA is financially healthy and has little risk of bankruptcy at the moment.
MHUA's Altman-Z score of 3.22 is fine compared to the rest of the industry. MHUA outperforms 66.84% of its industry peers.
MHUA has a debt to FCF ratio of 1.37. This is a very positive value and a sign of high solvency as it would only need 1.37 years to pay back of all of its debts.
The Debt to FCF ratio of MHUA (1.37) is better than 88.77% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that MHUA is not too dependend on debt financing.
The Debt to Equity ratio of MHUA (0.08) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.37 | ||
| Altman-Z | 3.22 |
ROIC/WACC1.25
WACC6.84%
2.3 Liquidity
A Current Ratio of 4.78 indicates that MHUA has no problem at all paying its short term obligations.
MHUA's Current ratio of 4.78 is fine compared to the rest of the industry. MHUA outperforms 72.19% of its industry peers.
A Quick Ratio of 4.74 indicates that MHUA has no problem at all paying its short term obligations.
MHUA has a Quick ratio of 4.74. This is in the better half of the industry: MHUA outperforms 75.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.78 | ||
| Quick Ratio | 4.74 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 13.80% over the past year.
MHUA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.81% yearly.
The Revenue has decreased by -6.00% in the past year.
Measured over the past years, MHUA shows a small growth in Revenue. The Revenue has been growing by 5.11% on average per year.
EPS 1Y (TTM)13.8%
EPS 3Y-20.04%
EPS 5Y-8.81%
EPS Q2Q%-47.95%
Revenue 1Y (TTM)-6%
Revenue growth 3Y2.91%
Revenue growth 5Y5.11%
Sales Q2Q%-5.91%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 1.12, the valuation of MHUA can be described as very cheap.
Based on the Price/Earnings ratio, MHUA is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 29.20, MHUA is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1.12 | ||
| Fwd PE | N/A |
4.2 Price Multiples
100.00% of the companies in the same industry are more expensive than MHUA, based on the Enterprise Value to EBITDA ratio.
MHUA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MHUA is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.36 | ||
| EV/EBITDA | 0.04 |
4.3 Compensation for Growth
MHUA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
MHUA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MEIHUA INTERNATIONAL MEDICAL
NASDAQ:MHUA (11/22/2024, 8:00:00 PM)
After market: 0.721 +0 (+0.25%)0.7192
+0.03 (+4.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap20.30M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1.12 | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.12% | ||
| ROE | 10.93% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 14.44% | ||
| PM (TTM) | 11.47% | ||
| GM | 33.97% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 4.78 | ||
| Quick Ratio | 4.74 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)13.8%
EPS 3Y-20.04%
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-6%
Revenue growth 3Y2.91%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y